IRCCS Istituto Tumori "G.Paolo II"

Bari 70124

1 studies enrolling now · 2 studies all time

What they study most

Locally Advanced Solid Tumor, Metastatic Solid Tumor, PD-L1 Negative, Triple Negative Breast Cancer

Studies at this site

• A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1) — Recruiting now
• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling